Ab initio prediction of the vibration-rotation-tunneling spectrum of HCl-(H2O)(2)

Contains fulltext : 14006.pdf (publisher's version ) (Open Access

Spectrum and vibrational predissociation of the HF dimer. I. Bound and quasibound states

Contains fulltext : 13891.pdf (publisher's version ) (Open Access

Theoretical study of the He-HF+ complex. I. The two asymptotically degenerate ground state potential energy surfaces

Contains fulltext : 13850.pdf (publisher's version ) (Open Access

Singlet-triplet excitation spectrum of the CO-He complex. II. Photodissociation and bound-free CO(a (3)Pi <- X-1 Sigma(+)) transitions

Contains fulltext : 13886.pdf (publisher's version ) (Open Access

Singlet-triplet excitation spectrum of the CO-He complex. I. Potential surfaces and bound-bound CO(a (3)Pi <- X-1 Sigma(+)) transitions

Contains fulltext : 13885.pdf (publisher's version ) (Open Access

Spectrum and vibrational predissociation of the HF dimer. II. Photodissociation cross sections and product state distributions

Contains fulltext : 13892.pdf (publisher's version ) (Open Access

‘Interests’ in medicine and the inadequacy of disclosure

Many papers published in the academic press sink without a trace, making no impression on clinical practice, health policy or public discourse. While the narrative review of melatonin-based therapies for depression published in the Lancet by Professor Ian Hickie and Associate Professor Naomi Rogers (2011) is unlikely to generate significant changes in clinical practice, it has generated enormous professional and media debate about the extent and impact of conflicts of interest in medicine arising from the relationships between health professionals and the pharmaceutical industry. In the disclosure accompanying the review, which highlighted the potential worth of the drug agomelatine, manufactured by Servier, both authors disclosed financial and professional links with Servier. The responses to this review, and to the disclosures made by the authors in the Lancet, on health media websites, in the lay press and in social media, have been largely critical – making either empirical claims, that the authors misreported the tolerability and/or efficacy of agomelatine, or moral claims, that the authors were conflicted or biased, had not adequately disclosed the extent of their interests, or that they or Elsevier (the publisher of the Lancet) may have gained some benefit from the publication (Barbui and Cipriani, 2012; Carroll, 2012; Dunlevy, 2012; Griffiths, 2012; Howland, 2012; Jureidini and Raven, 2012; Lloret-Linares et al., 2012; Serfaty and Raven, 2012). In a spirited response, the authors defended both their analysis and their professional ethics, arguing that they had appropriately attended to the processes of disclosure required by the Lancet for all contributors (Hickie and Rogers, 2012)

Diabatic intermolecular potentials and bound states of open-shell atom-molecule dimers: Application to the F(P-2)-H-2 complex

Contains fulltext : 13887.pdf (publisher's version ) (Open Access

Water pair potential of near spectroscopic accuracy. II. Vibration-rotation-tunneling levels of the water dimer

Contains fulltext : 14117.pdf (publisher's version ) (Open Access

Water pair potential of near spectroscopic accuracy. I. Analysis of potential surface and virial coefficients

Contains fulltext : 14099.pdf (publisher's version ) (Open Access